Indication

Obstructive sleep apnea syndrome

Obstructive sleep apnea syndrome is a chronic sleep-related breathing disorder characterized by recurrent episodes of partial (hypopnea) or complete (apnea) upper airway collapse during sleep despite ongoing ventilatory effort. Read more about Obstructive sleep apnea syndrome

2 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Obstructive sleep apnea syndrome therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Obstructive sleep apnea syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Obstructive sleep apnea syndrome.

Obstructive sleep apnea syndrome is a chronic sleep-related breathing disorder characterized by recurrent episodes of partial (hypopnea) or complete (apnea) upper airway collapse during sleep despite ongoing ventilatory effort.

Primarily involving the respiratory and cardiovascular systems, it commonly affects adults, particularly those with obesity, retrognathia, or increased neck circumference, though it can also occur in pediatric populations often secondary to adenotonsillar hypertrophy.

Pathophysiologically, repeated pharyngeal occlusions lead to intermittent arterial oxyhemoglobin desaturations, hypercapnia, recurrent cortical microarousals, and sympathetic surges.

Clinically, this results in disrupted, fragmented sleep architecture presenting with hallmark symptoms including disruptive snoring, witnessed nocturnal breathing pauses, choking or gasping awakenings, and severe excessive daytime sleepiness.

Personalize your experience

Follow Obstructive sleep apnea syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it